Categories
Business

First COVAX vaccine cargo arrives in Ghana, hope for creating world

A shipment of Covid-19 vaccines from the global COVAX vaccination program will arrive at Kotoka International Airport in Accra, Ghana on February 24, 2021.

Nipah Dennis | AFP | Getty Images

The first shipment of Covid-19 vaccines, delivered under the World Health Organization’s COVAX program, arrived in Ghana on Wednesday. This is a hopeful turning point for developing countries, who may be lagging behind in the global race to vaccinate a virus that has killed nearly 2.5 million people worldwide.

The flight brought 600,000 doses of the AstraZeneca vaccine, which is believed to be far easier to distribute in developing countries because it does not require extremely cold storage temperatures like the Pfizer-GenTech and Moderna vaccines.

The vaccines delivered on Wednesday will be prioritized for frontline medical professionals, those over 60 and those with pre-existing health conditions, according to the Ghanaian Ministry of Information.

“Today is the historic moment for which we have planned and worked so hard,” said UNICEF Executive Director Henrietta Fore in a joint statement from her agency and WHO Ghana.

“With the first shipment of cans, we can deliver on the promise of the COVAX Facility to ensure that people from less affluent countries are not left behind in the race for life-saving vaccines.”

Airport workers transport a shipment of Covid-19 vaccines from Covax’s global Covid-19 vaccination program onto dolls at Kotoka International Airport in Accra on February 24, 2021.

Nipah Dennis | AFP | Getty Images

COVAX is a global plan jointly led by WHO, an international vaccine alliance called Gavi, and the Coalition for Innovation in Epidemic Preparation.

While wealthier nations drive costly vaccine development and procurement, poorer countries suffer the consequences of inequality. Mark Suzman, executive director of the Bill & Melinda Gates Foundation, said in December that it may be too late for the vaccines to be distributed fairly as rich countries have already closed massive deals.

Wealthy nations, making up just 14% of the world’s population, had secured 53% of the world’s top performing coronavirus vaccines by December, according to a group of human rights activists called the People’s Vaccine Alliance.

COVAX was founded to ensure fair access to vaccines worldwide. By the end of 2021, 20% of people in the 92 poorest countries in the world are to be vaccinated through donations. Several other middle-income countries will purchase vaccines through COVAX on a self-funded basis. The plan this year is to deliver 2 billion doses of vaccines that have been recognized by WHO as safe and effective.

The recordings shipped to Ghana were produced by the Indian Serum Institute, which has been granted access to the intellectual property that enables it to manufacture vaccines based on the Oxford-AstraZeneca formula. The African Union has secured around 670 million doses of the Serum Institute’s vaccine for its member countries. The goal is for 60% of the 1.3 billion people in Africa to be vaccinated in the next two to three years.

“By far the fastest of all time”

“This is amazingly important. We want the gap between vaccinating the rich and the poor to be narrowed to zero,” said Hassan Damluji, assistant director of global politics and advocacy at the Bill & Melinda Gates Foundation, in an interview with Wednesday CNBC.

“We know that it usually takes decades for a vaccine to be developed and used for the first time in rich countries and then to reach the poorest people in the world. So Ghana receives its first shipment, just three months after the first vaccine rollouts World are more than extraordinary, “he said. “It is by far the fastest ever.”

A health worker applies a Sinovac CoronaVac Coronavirus Disease (COVID-19) vaccine to an elderly Citzen on February 18, 2021 in Sao Goncalo, near Rio de Janeiro, Brazil.

Ricardo Moraes | Reuters

The Gates Foundation has spent $ 1.75 billion fighting the coronavirus and has focused on vaccine development within COVAX.

Damluji noted that the program’s vaccine sourcing for poor countries was funded entirely by donors at a time when every developed world economy is in recession. “So it’s pretty remarkable,” he said.

Vaccine inequality will plunge countries into deeper poverty

The exclusion of poor countries from vaccination programs launched in wealthier countries will have devastating and lasting consequences, warn economists and public health experts that dramatically increase inequalities, hinder social and economic development and leave dozens of countries in significantly higher debt.

These inequalities, according to Oxford Economics, mean that the long-term economic damage of the pandemic will be twice as severe in emerging markets as it is in developed countries. A study by the RAND Corporation predicts the global economy will lose $ 153 billion in production annually if emerging economies do not get access to vaccines.

The countries of the COVAX donation plan are to receive doses that are appropriate for their populations: Afghanistan, for example, will receive 3 million doses, while Namibia will receive almost 130,000.

The Palestinian Territories expect to receive vaccines through COVAX in March. Iran and Iraq are part of COVAX, as are many lower-income countries in the Middle East. The wealthier Gulf States have sourced their own vaccine supplies directly from the manufacturers, while some, despite their own recessions, also contribute to the COVAX fundraising pool: Saudi Arabia donated $ 300 million and Qatar donated $ 10 million.

The U.S. hadn’t made a contribution to the COVAX facility under the Trump administration, but the Biden administration has pledged the largest donation to date – $ 4 billion.

Damluji pointed out the challenges of COVAX’s goals by running extensive vaccination campaigns in countries with faulty infrastructure, limited logistics and transportation, remote populations, and in some cases violence and war.

“This stuff is a moving target. Rightly the world’s attention is on it and wants to make sure it goes well,” he said. “But a few months ago we didn’t even know which vaccines would work. And now people need them on their doorstep.”

“There will be some complications as well,” he added. “It’s the biggest health procurement effort ever.”

Categories
Business

Dip in Unemployment Claims Gives Hope as New Virus Instances Ease

Following a pandemic-induced surge in layoffs due to new restrictions in many states, unemployment claims are falling, aided by a decline in new coronavirus cases.

Initial unemployment benefits fell last week, the Labor Department reported Thursday, and were well below levels in December and early January.

The number of new coronavirus cases is down a third from two weeks ago, prompting states like California and New York to relax restrictions on indoor eating and other activities. This has given workers in the hardest hit industries some respite.

813,000 new state benefit claims were made last week, compared to 850,000 the previous week. Adjusted for seasonal fluctuations, the value for the last week was 793,000, which corresponds to a decrease of 19,000.

There were 335,000 new entitlements to Pandemic Unemployment Assistance, a government-funded program for part-time workers, the self-employed, and others who are normally not eligible for unemployment benefits. That sum, which was not seasonally adjusted, fell from 369,000 the week before.

While claims remain extraordinarily high by historical standards, the improvement has raised hopes that layoffs will continue to slow as vaccinations spread and employers switch from laying off workers to adding workers.

“We’re stuck with this very high level of damage, but activity is picking up,” said Julia Pollak, employment economist at ZipRecruiter, an online job market. In fact, ZipRecruiter’s job postings are at 11.3 million, near the pre-pandemic 11.4 million level.

The improving pandemic situation has eased the burden on restaurants and bars, Ms. Pollak added. With nearly 10 million jobs deficit since the pandemic started and employers still cautious about hiring, the economy is facing major challenges.

Federal Reserve chairman Jerome H. Powell told the New York Business Club on Wednesday that policymakers should continue to focus on restoring employment, “Given the number of people who have lost their jobs and the likelihood that some struggle to find work in the post-pandemic economy. “

He found that employment for workers earning high wages had fallen by only 4 percent, but for the bottom quartile of those in work it was a “staggering 17 percent”.

Updated

Apr. 11, 2021 at 11:13 am ET

Many other signs of weakness remain. The Ministry of Labor reported that employers only created 49,000 jobs in January, underscoring the challenges facing the unemployed.

President Biden cited the poor performance to call for approval of a $ 1.9 trillion pandemic relief package. It would send $ 1,400 to many Americans, aid states and cities, and extend unemployment benefits, which is slated to run out to millions in mid-March.

The House Ways and Means Committee took an initial step on Wednesday when it began developing a measure that would continue emergency benefits through the end of August, increasing the weekly benefit premium from $ 300 to $ 400.

With the prospect of additional relief and a decrease in virus cases, some experts say a strong recovery is possible this year. Oxford Economics is forecasting economic growth of 5.9 percent in 2021, compared to a decline of 3.5 percent in the previous year.

According to economists at ZipRecruiter and another major online job board, Employers, employers are already putting out the welcome mat in certain areas.

Ms. Pollak said employer posts at ZipRecruiter in the past few days have offered hope. “We have seen employers exceed all of our expectations and show a lot of exuberance,” she said. “There are clear differences between different industries.”

In addition to strength in industries that benefit from the stay-at-home trend, such as B. Warehousing and deliveries, the recruitment of engineering, professional and business services has recently shown signs of life.

“Companies are looking to the future and are somewhat optimistic,” said Ms. Pollak.

AnnElizabeth Konkel, an economist at Indeed Hiring Lab, added that demand for pharmacists was up 23 percent year-over-year while openings for drivers were up 18 percent. “Everything is directly related to the pandemic,” said Ms. Konkel.

Nevertheless, there were regional differences. In cities like Washington, Seattle, Boston, and San Francisco, where many people work remotely, there were fewer vacancies in some areas than in places with more people back in the office.

“People don’t come to their local café on their way to work or stop at a store to pick up something when they work at home,” said Ms. Konkel, and that affects attitudes.

Restaurant openings have declined for a year, as have positions in arts and entertainment, hospitality and tourism.

At ZipRecruiter, the energy industry posted more jobs after heavy losses at the beginning of the pandemic. Manufacturing has also seen more openings lately.

“Some of the losers are finally coming back a bit,” said Ms. Pollak. “But so many industries are impossible to resume while the pandemic continues.”

Categories
Business

‘We Are Forgotten’: Grocery Employees Hope for Increased Pay and Vaccinations

HAC, the Oklahoma company that owns Cash Saver and Homeland, is employee owned. Its managing director, Marc Jones, said last year’s initial hero pay was “a reflection of the crowd in our stores, and as that wave subsided, it seemed like the time to end it.” It’s been a huge expense for the company, which has around 80 stores, 3,400 employees, and competes with Walmart.

Even with a better year than usual, groceries are “a particularly profitable” business, Jones said. By March he said, “It was a big question if the local grocery store would even survive and if everyone would go online.”

Ms. Sockwell said she was more concerned about the vaccination delay for food workers, especially given that her colleagues tended to work every hour they could, at the minimum wage.

“Most of my employees barely have a high school diploma,” said Ms. Sockwell, whose local UFCW unit tried to get Oklahoma officials to prioritize vaccination for food workers. “They want to do whatever they can to keep food and electricity in their home.”

She added, “We are simple workers who don’t need bachelor’s and master’s degrees, but we’re still human.”

At least 13 states in at least some counties have approved some grocery store employees for the Covid-19 vaccine. They are Alabama, Arizona, California, Delaware, Illinois, Kansas, Kentucky, Maryland, Nebraska, New York, Pennsylvania, Virginia, and Wyoming.

Categories
Health

How New Vaccine Information Provides Hope for Spring, if Sufficient Individuals Get the Pictures

Als Anfang November im ganzen Land Coronavirus-Infektionen zunahmen – und sich die Aussicht auf einen langen, dunklen Winter abzeichnete – war nicht klar, ob sich einer der in der Entwicklung befindlichen Impfstoffe durchsetzen würde.

Jetzt, drei Monate später, sieht das Bild ganz anders aus. Im ganzen Land werden zwei hochwirksame Covid-Impfstoffe eingeführt. Drei andere scheinen etwas weniger robust zu sein, bieten aber dennoch einen starken und in einigen Fällen vollständigen Schutz vor schweren Krankheiten und Todesfällen.

Alleine in der vergangenen Woche berichteten Novavax und Johnson & Johnson, dass ihre Impfstoffe einen guten Schutz bieten, auch gegen neue, ansteckendere Varianten des Coronavirus. Eine neue Analyse der Universität Oxford legt nahe, dass der mit AstraZeneca entwickelte Impfstoff die Übertragung verlangsamen kann und besonders gut funktioniert, wenn sich die zweite Dosis verzögert.

Nach einem Sputter-Start beschleunigt sich die Impfung in den USA: Mehr als 27 Millionen Amerikaner haben eine erste Dosis erhalten, und mehr als sechs Millionen wurden vollständig geimpft. Dieses Tempo hat sich so beschleunigt, dass Präsident Biden, der kritisiert wurde, dass das Ziel seiner Regierung, in seinen ersten 100 Tagen im Amt 100 Millionen Schüsse abzugeben, zu bescheiden war, letzte Woche das Ziel auf 150 Millionen Schüsse nach oben korrigierte.

“Wir haben einen langen Weg zurückgelegt”, sagte Akiko Iwasaki, Immunologe an der Yale University. “Wir leben immer noch mit tödlichen Krankheiten, weil wir nicht genug Menschen geimpft haben, aber sobald wir dies tun, wird sich die Art und Weise, wie wir mit diesem Virus leben und umgehen, wirklich ändern.”

Aber auch wenn es im Frühjahr und Sommer Grund zur Hoffnung gibt, bleiben viele Experten des öffentlichen Gesundheitswesens in den nächsten Monaten pessimistisch. Mehrere warnten, dass die Welt bei weitem nicht frei von einer Pandemie sei, bei der in den USA fast 450.000 Menschen und weltweit 2,2 Millionen Menschen ums Leben gekommen seien.

In reichen Ländern haben sich die Impfungen beschleunigt, aber ärmere Länder bleiben zurück. In den Vereinigten Staaten erhalten wohlhabendere weiße Einwohner häufiger Zugang zu dem Impfstoff als Schwarze und Latinos, die überproportional von der Pandemie betroffen sind.

Obwohl die Fälle in den Vereinigten Staaten in den letzten Wochen zurückgegangen sind, befinden sie sich immer noch auf einem Niveau, das fast doppelt so hoch ist wie der Höhepunkt des letzten Sommers, selbst wenn einige Großstädte wie Chicago und New York Speisen im Innenbereich und andere Aktivitäten eröffnen. Die Rücknahme von Beschränkungen kommt auch, da ansteckende neue Varianten den Globus umkreisen, von denen einige die Wirksamkeit der Impfstoffe zu verringern scheinen.

Dr. Eric Topol, Experte für klinische Studien bei Scripps Research in San Diego, erinnerte sich daran, dass er bereits im Dezember hoffnungsvoll war, dass die Pandemie in den USA bis Juni gezähmt werden könnte, dank der Flut ermutigender Impfstoffdaten. Aber als das Bild in den letzten Wochen klarer wurde, was die Bedrohung durch neue, ansteckendere Varianten des Virus betrifft, die sich in anderen Ländern ausbreiten, die in den Vereinigten Staaten aufgetaucht sind – insbesondere die Variante B.1.1.7, die erstmals in Großbritannien – sein Optimismus hat nachgelassen.

“Die Varianten haben alles verändert”, sagte Dr. Topol.

Vorläufige Studien haben gezeigt, dass die Impfstoffe von Pfizer, Moderna, Novavax und Johnson & Johnson gegen die Variante B.1.1.7 zu wirken scheinen und dass sie auch – wenn auch weniger – gegen die erstmals in Südafrika identifizierte Variante wirksam sind. Selbst im Fall dieser Variante zeigte die Studie von Johnson & Johnson, dass sie immer noch vor schweren Krankheiten schützt.

Einige der ersten Menschen, die geimpft wurden, sehen einen Weg aus der Pandemie.

Bei Bloom Senior Living, einer Kette von Seniorenwohneinrichtungen im Südosten und Mittleren Westen, haben Beamte an fünf ihrer neun Standorte nach und nach begonnen, ihre Türen für Besucher in Innenräumen wieder zu öffnen.

Diese Entscheidungen waren auf die Infektionsraten in der Gemeinde zurückzuführen, aber ein weiterer Faktor hat die Beamten von Bloom mit der Idee vertraut gemacht: 96 Prozent der Bewohner von Einrichtungen, die von Apothekenimpfungsteams besucht wurden, haben zugestimmt, einen Schuss zu bekommen.

“Es bedeutet alles für sie, ihre erwachsenen Kinder und hoffentlich schließlich ihre Enkelkinder sehen zu können – um das Gefühl zu haben, wieder ein Leben zu führen”, sagte Bradley Dubin, Direktor der Firma, die die Bloom-Einrichtungen besitzt.

Die Auswirkungen der US-Impfkampagne zeigen sich möglicherweise in den Daten. Die Anzahl der bestätigten Coronavirus-Fälle bei Pflegebewohnern ging in den ersten drei vollen Wochen, in denen Impfstoffe in Pflegeheimen verabreicht wurden, zurück. Dies geht aus Daten hervor, die Pflegeheime den Zentren für die Kontrolle und Prävention von Krankheiten melden. Es ist nicht klar, wie viel davon auf Impfungen zurückzuführen ist.

In Vermont, wo 85 Prozent der Menschen in Langzeitpflegeeinrichtungen zugestimmt haben, mindestens ihren ersten Impfstoff zu bekommen, sagten Beamte diese Woche, dass sie planen, die Besuchsbeschränkungen in diesen Häusern bald zu lockern, obwohl sie dies nicht festgelegt haben ein Datum dafür.

Die Impfkampagne in Pflegeheimen ist Teil einer Impfkampagne in den USA, die nach wochenlangen frustrierenden Verzögerungen an Dynamik gewonnen hat. Die Vereinigten Staaten geben derzeit durchschnittlich 1,3 Millionen Schüsse pro Tag ab, und in einigen Staaten wie Alaska und New Mexico haben mehr als 10 Prozent der Bevölkerung mindestens eine von zwei erforderlichen Dosen eines Impfstoffs erhalten.

Staatliche und lokale Gesundheitsbehörden richten Massenimpfaktionen durch, beispielsweise im Dodger Stadium in Los Angeles, und arbeiten mit der Nationalgarde und der Federal Emergency Management Agency zusammen. Die Kampagne wird auch zunehmend auf Apotheken ausgeweitet, in denen viele Amerikaner daran gewöhnt sind, Impfstoffe zu erhalten.

Auch an der Versorgungsfront gibt es hoffnungsvolle Anzeichen.

Am Dienstag kündigte die Bundesregierung an, den Staaten für die nächsten drei Wochen mindestens 10,5 Millionen Dosen Coronavirus-Impfstoffe zuzuteilen. Gleichzeitig spricht Moderna mit der Food and Drug Administration über die Befüllung der Durchstechflaschen mit 15 statt der derzeit 10 Dosen. Diese Änderung könnte die Produktion des Unternehmens um 50 Prozent steigern.

Darüber hinaus hat Pfizer angekündigt, bis Mai zwei Monate vor dem geplanten Termin 200 Millionen Dosen in die USA liefern zu können, da jetzt eine zusätzliche Dosis in den Impfstoffflaschen gezählt wird.

Covid19 Impfungen >

Antworten auf Ihre Impfstofffragen

Bin ich in meinem Bundesstaat für den Covid-Impfstoff berechtigt?

Derzeit können mehr als 150 Millionen Menschen – fast die Hälfte der Bevölkerung – geimpft werden. Aber jeder Staat trifft die endgültige Entscheidung darüber, wer zuerst geht. Die 21 Millionen Beschäftigten im Gesundheitswesen des Landes und drei Millionen Einwohner von Langzeitpflegeeinrichtungen waren die ersten, die sich qualifizierten. Mitte Januar forderten Bundesbeamte alle Bundesstaaten auf, die Berechtigung für alle über 65-Jährigen und für Erwachsene jeden Alters mit Erkrankungen zu öffnen, bei denen ein hohes Risiko besteht, dass sie schwer krank werden oder an Covid-19 sterben. Erwachsene in der Allgemeinbevölkerung stehen am Ende der Reihe. Wenn Gesundheitsbehörden von Bund und Ländern Engpässe bei der Verteilung von Impfstoffen beseitigen können, sind alle ab 16 Jahren bereits im Frühjahr oder Frühsommer förderfähig. Der Impfstoff wurde bei Kindern nicht zugelassen, obwohl derzeit Studien durchgeführt werden. Es kann Monate dauern, bis ein Impfstoff für Personen unter 16 Jahren verfügbar ist. Aktuelle Informationen zu den Impfrichtlinien in Ihrer Region finden Sie auf Ihrer staatlichen Gesundheitswebsite

Ist der Impfstoff frei?

Sie sollten nichts aus eigener Tasche bezahlen müssen, um den Impfstoff zu erhalten, obwohl Sie nach Versicherungsinformationen gefragt werden. Wenn Sie nicht versichert sind, sollten Sie den Impfstoff trotzdem kostenlos erhalten. Der Kongress hat in diesem Frühjahr ein Gesetz verabschiedet, das es Versicherern verbietet, eine Kostenteilung wie eine Zuzahlung oder einen Selbstbehalt anzuwenden. Es bestand aus zusätzlichen Schutzmaßnahmen, die es Apotheken, Ärzten und Krankenhäusern untersagten, Patienten, einschließlich nicht versicherter Patienten, in Rechnung zu stellen. Trotzdem befürchten Gesundheitsexperten, dass Patienten in Schlupflöcher geraten, die sie für Überraschungsrechnungen anfällig machen. Dies kann bei Personen der Fall sein, denen zusammen mit ihrem Impfstoff eine Arztbesuchsgebühr berechnet wird, oder bei Amerikanern, die bestimmte Arten der Krankenversicherung haben, die nicht unter die neuen Vorschriften fallen. Wenn Sie Ihren Impfstoff von einer Arztpraxis oder einer Notfallklinik erhalten, sprechen Sie mit ihnen über mögliche versteckte Kosten. Um sicherzugehen, dass Sie keine Überraschungsrechnung erhalten, ist es am besten, Ihren Impfstoff an einer Impfstelle des Gesundheitsministeriums oder in einer örtlichen Apotheke zu erhalten, sobald die Aufnahmen breiter verfügbar sind.

Kann ich wählen, welchen Impfstoff ich bekomme?Wie lange hält der Impfstoff? Brauche ich nächstes Jahr noch einen?

Das ist zu bestimmen. Es ist möglich, dass Covid-19-Impfungen genau wie die Grippeimpfung zu einem jährlichen Ereignis werden. Oder es kann sein, dass der Nutzen des Impfstoffs länger als ein Jahr anhält. Wir müssen abwarten, wie dauerhaft der Schutz vor den Impfstoffen ist. Um dies festzustellen, werden Forscher geimpfte Menschen aufspüren, um nach „Durchbruchsfällen“ zu suchen – jenen Menschen, die trotz Impfung an Covid-19 erkranken. Dies ist ein Zeichen für eine Schwächung des Schutzes und gibt Forschern Hinweise darauf, wie lange der Impfstoff hält. Sie werden auch die Spiegel von Antikörpern und T-Zellen im Blut geimpfter Personen überwachen, um festzustellen, ob und wann ein Auffrischungsschuss erforderlich sein könnte. Es ist denkbar, dass Menschen alle paar Monate, einmal im Jahr oder nur alle paar Jahre Booster benötigen. Es geht nur darum, auf die Daten zu warten.

Benötigt mein Arbeitgeber Impfungen?Wo kann ich mehr erfahren?

Hunderte Millionen zusätzlicher Impfstoffdosen von Johnson & Johnson, AstraZeneca und Novavax könnten das Angebot bis zum Sommer weiter ausbauen.

Obwohl die neueren Impfstoffe nicht die gleiche hohe Gesamtwirksamkeit zeigten wie Moderna und Pfizer im letzten Jahr und zwei noch keine Ergebnisse aus ihren klinischen Studien in den USA gemeldet haben, haben mehrere Impfstoffexperten auf ein übersehenes, aber vielversprechendes Detail hingewiesen: Alle Die Impfstoffe haben einen hervorragenden Schutz gegen die schwere Form von Covid-19 gezeigt, die zu Krankenhausaufenthalten und zum Tod führt.

“Was ich vermeiden möchte, ist, dass Menschen bis zum Krankenhausaufenthalt krank werden oder auf tragische Weise von Covid-19 sterben”, sagte Dr. Stefan Baral, Epidemiologe an der Johns Hopkins Bloomberg School of Public Health. Die Nachricht, dass die Impfstoffe vor diesen Ergebnissen schützen, sei “unglaublich erhebend”.

Die Herausforderung besteht jedoch darin, “an einen Punkt zu gelangen, an dem tatsächlich genug Menschen geimpft werden können, um diese Vorteile auf Bevölkerungsebene zu sehen”, sagte Angela Rasmussen, Virologin am Center for Global Health Science and Security der Georgetown University. “Meine derzeit größte Sorge ist, dass die Menschen nicht die Vorsichtsmaßnahmen treffen, die sie kurzfristig treffen sollten, damit wir in den kommenden Monaten bequem an diesen Punkt gelangen können.”

Experten haben gesagt, es sei noch zu früh, um die allgemeinen Auswirkungen der Massenimpfung auf die öffentliche Gesundheit in den USA zu erkennen. Aber ein anderes Land – Israel – bietet Hoffnung. Forscher in diesem Land, das weltweit führend bei der Impfung seiner Bevölkerung ist, haben nach nur einer Dosis Pfizers Schuss einen signifikanten Rückgang der Infektion und nach zwei Schüssen bessere Ergebnisse als erwartet gemeldet, vorläufige Daten, die Experten als ermutigend beschrieben haben.

“Dies ist, was passieren kann, wenn die Dinge richtig laufen”, sagte Dr. Iwasaki aus Yale.

Um dieses Ziel zu erreichen, müssen die Vereinigten Staaten jedoch schnell handeln und das Virus in Schach halten, da hoch ansteckende Varianten häufiger auftreten.

Die Gesundheitsbehörden müssen auch den Zugang zu den Impfstoffen für diejenigen verbessern, die am anfälligsten für Covid-19 sind. Frühe Impfdaten, die unvollständig sind, zeigen, dass Menschen aus wohlhabenderen, weißen Gegenden Impfterminsysteme überflutet haben und einen übergroßen Anteil am begrenzten Angebot haben.

Die gleiche Dynamik spielt sich auch global ab. Wohlhabende Länder haben einen Großteil des weltweiten Impfstoffangebots gekauft, was bedeutet, dass viele ärmere Länder bei der Impfung ihrer Bürger wahrscheinlich zurückbleiben werden. Am Mittwoch kündigte ein internationales Programm zur kostengünstigen oder kostenlosen Lieferung von Covid-19-Impfstoffen an Länder auf der ganzen Welt Pläne an, bis zum 30. Juni mehr als 300 Millionen Dosen abzugeben. Dies reicht jedoch nicht aus, um alle zu impfen.

“Ich denke, in der reichen Welt haben wir ein gutes Gefühl für Impfstoffe, aber weltweit ist es eine andere Geschichte”, sagte Marc Lipsitch, Professor für Epidemiologie und Direktor des Zentrums für Dynamik übertragbarer Krankheiten an der Harvard TH Chan School of Gesundheitswesen.

Dr. Baral von Johns Hopkins kümmert sich um die Bewohner mehrerer Obdachlosenunterkünfte in Toronto. Letzten Monat, sagte er, habe er Bewohner in einem Tierheim für ältere Männer geimpft. “Es war dieses unglaubliche Gefühl der Erleichterung – man konnte es auf ihren Gesichtern sehen”, sagte er. “Wir sind an einem anderen Ort als vor sechs Monaten.”

Categories
World News

The primary Covid-19 vaccines deliver People hope in small doses.

Some of the medical centers that have seen the worst coronavirus outbreak in the United States found the darkness that has long filled their corridors replaced with exhilaration and hope on Monday as healthcare workers first participated in a targeted mass vaccination campaign at the end of the pandemic.

Hundreds of those who have been on the front lines fighting Covid-19 – a nurse from an intensive care unit in New York, an emergency doctor from Ohio, a housekeeper in Iowa – received vaccinations in emotional ceremonies watched by people around the country .

“I have a feeling healing is coming,” said Sandra Lindsay, an intensive care director who was among the first health workers to be vaccinated on Monday morning at the Long Island Jewish Medical Center in Queens.

The vaccinations came when the nation topped 300,000 coronavirus deaths, a higher number than any other country. Even when there was applause in hospitals, many intensive care units remained almost full.

Doctors, nurses, aides, cleaners, and at least one manager who said he would get the vaccine early to encourage all staff to do the same.

Dr. Jason Smith, the first Kentuckian to receive the Covid-19 vaccine, showed off the smiley face patch a health care worker put on his arm. “I didn’t even feel it,” he said.

A group of nuns in Sioux Falls, SD, blessed the vaccine upon arrival before it was placed in a freezer.

Seth Jackson, an Iowa City nurse, cried on the way to the hospital to get his shot. Robin Mercier, a Rhode Island nurse, was delighted to be one step closer than she could kiss her grandchild.

For many Americans who lost loved ones to Covid-19, the introduction of vaccination has been bittersweet. It didn’t come soon enough for Mary Smith’s husband Mike, who died of the virus in November at the age of 64.

“It was so close,” said Ms. Smith, who lives outside of Peoria, Illinois, on Monday.

She expressed frustration with people who said they did not trust the vaccine. “These people who say, ‘I don’t get it,’ all I can say is, ‘Why? Have you lost your mind? Added Ms. Smith. “Didn’t you see how many people died? That is real.'”

Categories
Entertainment

Evaluation: Discovering Hope in an Unfinished Pam Tanowitz Premiere

On Saturday, the Joyce Theater broadcast a premiere by choreographer Pam Tanowitz, who started the program with the words: “It’s not really finished yet.”

This wasn’t a confession of negligence or an excuse for over-planning, though Ms. Tanowitz, who was one of New York’s most sought-after choreographers before the pandemic, has been remarkably busy lately, doing video dancing for both the New York City Ballet and American Ballet Theater.

Rather, Ms. Tanowitz’s words were self-explanatory in the manner of an artistic statement. The title of the new work is “Finally unfinished: Part 1”. This was the second half of the 35-minute event, which was available on request through December 26th, coupled with another recently published work, “Gustave Le Gray, No. 2”. ”

What we have here are parts, parts, versions, recycled matter. A program note shows that “Finally unfinished” is based on choreographic material from works that Ms. Tanowitz previously presented at Joyce. “Gustave Le Gray, No. 2” is related to “Gustave Le Gray, No. 1” which was created for the Miami City Ballet and the Dance Theater of Harlem last year (and slated for the City Ballet 2022 schedule) .

And there is already a “Finally Unfinished: Part 2”. It is a website, a “digital box of curiosities” (funnily designed by Jeremy Jacob like a cut-and-paste scrapbook with stop-motion animation) that brings together some of Ms. Tanowitz’s inspirations for dance.

The livestream event is also a kind of scrapbook. It’s an event in the Merce Cunningham sense of combining old pieces in a new order for a new occasion and space.

The “unfinished” deal with titles and texts is a view of the continuity of a choreographer’s life. For Ms. Tanowitz, the distinction between works is possibly less important than their common origin as filament that she and her employees keep turning. “It’s never finished for me,” she says, referring to each piece, but also the process and practice of dancing. At the moment, the humility of testifying is a sign of hope.

But if their work is one piece to them, that doesn’t mean the pieces are all the same. The first, “Gray, No. 2”, which is set on a Caroline Shaw score, which is itself a revision of a Chopin mazurka, is a highly ordered composition for four people that quietly absorbs in its changing configurations, with a dancer often swings to a new position The whole group moves. The work resists the buoyancy, a feeling of weight or fatigue, which the dancers eventually no longer resist and sink to the ground.

However, this is not the end of the program. Because the much wilder and fragmented “Finally unfinished” begins when a camera follows Melissa Toogood’s cool fire into the wings. Soon enough the dancers – seven of them now – will be walking into the aisles, seats and the balcony. And this theater, which was dark and empty for most of this year, is enlivened by elegant, eccentric, brilliant dance.

This is Joyce’s second experiment in live streaming. (The first, in which seven dancers at a time recorded Molissa Fenley’s grueling solo “State of Darkness,” was in October, and recordings are available until January 10th.) Not everything that distinguishes itself as cinematography is less of a work for the camera as a substitute for being in the theater. In fact, it is a love letter to what Joyce was and should become again.

In the score for “Endlich unfinished”, which lies between confusing and loud contributions by Dan Siegler and Ted Hearne, there is a recording of the stage manager’s instructions (“Go, Victor!”) And announcements during a Pam Tanowitz dance performance in 2014 at Joyce . (“Please turn off your electronic devices” is poignant when you hear about an electronic device that gives you the only access to the factory.)

The costumes that Reid Bartelme and Harriet Jung designed for previous Tanowitz plays at Joyce are also related to the theater, reproducing the red curtain, chair upholstery, and less stylish carpeting. It’s all loving mockery that pokes fun at the Joyce’s frumpiness while respecting her story as an essential home for dance: the tactile, personal experience for which this digital version is a placeholder.

At the end of the performance, the dancers look out onto the stage from their seats to represent the missing audience. This captures in a picture what “Finally unfinished, Part 2” says in words: “This is not the end. Return to learn more. “

Pam Tanowitz dance

Available until December 26th, joyce.org.

Categories
World News

Britain rolls out the Pfizer vaccine, an enormous process however an indication of hope.

The UK’s National Health Service delivered its first footage of the Pfizer BioNTech Covid-19 vaccine on Tuesday. He opened a mass vaccination campaign with little precedent in modern medicine, making the British the first in the world to receive a clinically approved, fully tested vaccine for the disease.

Vaccine centers across the country are starting to carefully deliver vaccinations on a tight schedule, as the vaccine must be used or thrown away within five days of being thawed. “We do this with military precision, and indeed the military helped us with our planning,” said Fiona Kinghorn, who oversaw the launch of the vaccine at a site in Cardiff, Wales.

The effort marks a turning point in the remarkable race to manufacture a vaccine and global effort to end a pandemic that killed 1.5 million people worldwide. At a Welsh vaccination center, a retired nurse on the facility described the reaction of her youngest patient, another nurse. “She just cried and said it was such an emotional day,” she said, adding, “I think partly because she worked on a Covid ward so she saw the consequences and probably the results. Me assume she saw a lot. “

At 6:31 am Tuesday, 90-year-old Margaret Keenan, a former jeweler, rolled up the sleeve of her Merry Christmas T-shirt for the first shot, and her image quickly became a symbol of hope and resilience .

“I feel so privileged to be the first person to be vaccinated against Covid-19,” said Ms. Keenan, who lives in Coventry, Central England. “That means I can finally look forward to spending time with family and friends in the New Year after being alone for most of the year.”

UK regulators jumped ahead of their American counterparts last week to approve a coronavirus vaccine, which angered the White House and sparked a lively debate over whether the UK had moved too quickly or whether the United States was wasting valuable time when the virus was around 2,200 People killed Americans one day in the past week, as of Monday.

President Trump planned on Tuesday to issue an executive order proclaiming that other nations will not receive US vaccines until after Americans are vaccinated. This guideline seemed to have no real teeth, but it was indicative of the heated race to secure dose deliveries.

For the people who were vaccinated in the UK, including doctors and nurses who joined the country’s National Health Service this year, the footage was an early glimpse into life after the pandemic. Except for Ms. Keenan, none got as much attention as William Shakespeare, who was second in a shot in Coventry and whose real name, the National Health Service confirmed, is William Shakespeare. Twitter used the news of his vaccination as an opportunity for an enthusiastic play on words and jokes about the taming of the flu and the gentlemen of Corona.

“Today is a great day for medicine and the future,” said Chris Whitty, chief medical officer for England, on Tuesday. (A previous version of this article incorrectly stated that he was the chief medical officer for the whole of the UK.)

The first 800,000 doses of Pfizer BioNTech vaccine for the UK have been shipped from a manufacturing facility in Belgium to government warehouses in the UK and then to hospitals in the past few days.

50 hospitals will manage the admissions until the government can refine a plan for delivery to nursing homes and doctor’s offices. The vaccine must be transported in temperatures similar to the south pole before it can be stored in a regular refrigerator for five days, Pfizer said. Doctors and nurses, certain people aged 80 and over, and nursing home workers are given the vaccine first.

Some doctors and nurses have received invitations to register for appointments in the past few days. The first shots are for those who are at the highest risk of serious illness. The government has indicated that people aged 80 and over who have already had a doctor’s visit or are discharged from certain hospitals for this week will also be among the first to receive gunfire.

Nursing home residents, who should actually be the government’s top priority, will be vaccinated in the coming weeks once health officials start distributing doses across hospitals.

Hundreds of people are still dying from the virus every day in the UK, and the country has taken into account Christmas travel that scientists fear will trigger another surge in infections.

“It’s amazing to see the vaccine, but we can’t afford to relax right now,” British Prime Minister Boris Johnson said Tuesday morning when visiting a London hospital. Trying to calm a recipient’s nerves over needles, he suggested, “I always try to think of something else – recite poetry.”

Ms. Keenan, the first vaccine recipient, showed no such nerves. Nicola Sturgeon, Scotland’s first minister, said on Twitter that she had “a little lump in her throat” when Ms. Keenan was shot.

“Feels like a milestone after a tough year for everyone,” added Ms. Sturgeon.

Ms. Keenan’s shot was administered by May Parsons, a nurse originally from the Philippines who has worked for the National Health Service for 24 years.

“The past few months have been difficult for all of us who work in the NHS,” she said, “but now it feels like there is light at the end of the tunnel.”